API change not reported during WHO PQ assessment – CAPA expectations for PQ approval



Published on 29/01/2026

Addressing Unreported API Changes During WHO PQ Assessments: A Practical Playbook

In the fast-paced pharmaceutical manufacturing environment, maintaining compliance with WHO prequalification (PQ) standards is crucial for regulatory success. However, instances where active pharmaceutical ingredient (API) changes are not reported during WHO PQ assessments can lead to significant challenges. This article aims to equip professionals in manufacturing, quality control (QC), quality assurance (QA), engineering, and regulatory affairs (RA) with actionable guidance to effectively address this issue.

By following this playbook, readers will understand how to identify symptoms, evaluate likely causes, implement immediate containment actions, and develop a comprehensive corrective and preventive action (CAPA) strategy, ensuring compliant practices and inspection readiness.

Symptoms/Signals on the Floor or in the Lab

Before a deeper exploration into causes, recognizing the symptoms signaling an unreported API change is paramount. The following signals may indicate compliance issues:

  • Inconsistencies in batch records compared to standard operating procedures (SOPs)
  • Deviation reports linked to unexpected
product quality attributes
  • Intermittent observations during inspections indicating API variability
  • Invalid results from routine analytical testing
  • Unaddressed discrepancies in documentation from prior quality audits
  • Strong communication channels across departments can facilitate the identification of these symptoms in real-time, enabling a quicker response to potential issues.

    Likely Causes

    Once symptoms are identified, it is essential to categorize potential causes of the unreported API change. This can be grouped into six categories: Materials, Method, Machine, Man, Measurement, and Environment. Below is a brief overview of each category:

    Category Potential Causes
    Materials Variability in raw materials sourced or changes in supplier specifications.
    Method Changes in the manufacturing process not documented, leading to deviations.
    Machine Equipment malfunctions or configuration errors affecting product quality.
    Man Lack of training or awareness among personnel about change control procedures.
    Measurement Inaccurate analytical testing methods or inappropriate calibration of instruments.
    Environment Changes in manufacturing conditions affecting API stability or performance.

    Immediate Containment Actions (First 60 Minutes)

    When an unreported API change is suspected, immediate containment actions are necessary. The objective is to minimize further risk and stabilize the situation:

    1. Stop production immediately to prevent further batches from being affected.
    2. Isolate any raw materials or finished products potentially impacted by the change.
    3. Notify the QA and QC teams to initiate an investigation.
    4. Document the initial observations and actions taken in real-time to establish a clear timeline.
    5. Communicate with regulatory affairs to prepare for potential implications regarding compliance.

    Investigation Workflow

    After immediate containment, initiating an investigation is vital. Follow a structured workflow that includes:

    1. Data Collection: Gather batch records, deviation reports, change controls, and relevant SOPs.
    2. Personnel Interviews: Consult with involved staff to understand changes and processes.
    3. Document Review: Assess documentation integrity to identify discrepancies regarding API specifications.
    4. Testing: Conduct necessary analytical testing on samples from affected batches.

    Interpretation of collected data should focus on identifying trends or discrepancies against established norms to pinpoint the root cause.

    Root Cause Tools

    Utilizing effective root cause analysis (RCA) tools is crucial. The following methodologies can be employed based on the situation:

    • 5-Why Analysis: Best for identifying the underlying causes of specific problems by repeatedly asking “why?”.
    • Fishbone Diagram: Useful for visualizing potential causes grouped by categories, facilitating brainstorming among teams.
    • Fault Tree Analysis: Effective in evaluating complex issues, particularly when multiple failure paths are likely.

    Each tool has unique strengths, and understanding when to use which can enhance the effectiveness of the investigation.

    CAPA Strategy

    Based on the findings from your investigation, develop a CAPA strategy that includes:

    1. Correction: Address and rectify the immediate issue, ensuring the quality of any affected products.
    2. Corrective Action: Implement measures to resolve the root cause and prevent recurrence. This could involve retraining staff or updating SOPs.
    3. Preventive Action: Establish new controls or processes to monitor and avoid similar issues in the future.

    Engage cross-functional teams to ensure that all relevant departments contribute to the development and implementation of the CAPA.

    Control Strategy & Monitoring

    A robust control strategy is necessary to monitor ongoing compliance. This should include:

    • Statistical Process Control (SPC) to evaluate batch-to-batch variability.
    • Regular sampling and verification of APIs to ensure consistency with specifications.
    • Setting up alarms for production monitoring to detect deviations swiftly.

    Regular reviews of control data can help prevent non-compliance and ensure high-quality production.

    Related Reads

    Validation / Re-qualification / Change Control Impact

    Identify whether the incident necessitates re-evaluation of validation efforts or change control procedures. Consider the following:

    • Does the API change affect previously validated processes? If yes, a re-validation may be required.
    • Are there updates needed for the change control documentation, reflecting the new API characteristics?
    • Ensure any alterations to equipment or processes are documented and validated, aligning with regulatory requirements.

    Engaging with regulatory bodies early in the process can aid in navigating compliance needs, minimizing potential disruptions.

    Inspection Readiness: What Evidence to Show

    Preparing for inspections demands meticulous documentation and evidence of compliance efforts. Ensure you have the following readily available:

    • Records of initial findings and actions taken during the detection of the issue.
    • Detailed documentation of the investigation workflow and findings.
    • CAPA plans with assigned responsibilities and timelines.
    • Updated SOPs reflecting changes and amendments made.
    • Comprehensive training logs to demonstrate employee understanding of revised processes.
    • Batch records and testing results showcasing compliance with quality standards.

    An organized, thorough documentation approach not only supports internal audits but also reinforces transparency for external regulatory inspections.

    FAQs

    What is the consequence of not reporting an API change during WHO PQ assessment?

    Consequences may include regulatory penalties, delays in approvals, product recalls, and potential harm to patient safety.

    How can we prevent unreported API changes in the future?

    Implement strict change control processes, conduct regular training sessions, and establish a robust communication framework across teams.

    What role does quality control play in detecting API changes?

    Quality control is critical in identifying discrepancies through routine testing and monitoring of batch attributes against specifications.

    Why is immediate containment important?

    Immediate containment minimizes the risk of widespread non-compliance and safeguard product integrity effectively.

    What should be included in a CAPA plan?

    A CAPA plan should detail corrections, corrective actions, preventive measures, timelines, and responsible personnel.

    How often should training regarding API changes be conducted?

    Training should occur whenever there are updates in procedures or materials and at least annually to reinforce compliance knowledge.

    What documentation is crucial during a CAPA investigation?

    Documentation should include investigation findings, CAPA plans, corrective action timelines, and evidence of implementation.

    When is re-validation necessary?

    Re-validation is necessary when changes to processes, materials, or equipment may impact product quality or compliance.

    How do we ensure ongoing compliance after rectifying an API change?

    Continuous monitoring, regular audits, employee training, and adherence to updated SOPs are essential for sustained compliance.

    What steps should be taken if a regulatory inspection finds API issues during PQ assessment?

    Immediate containment, followed by a thorough investigation, CAPA implementation, and transparent communication with regulatory agencies are vital steps.

    Pharma Tip:  CAPA effectiveness doubted during variation management – PQ assessment risk and mitigation